Literature DB >> 27378464

Development of the Canadian Syncope Risk Score to predict serious adverse events after emergency department assessment of syncope.

Venkatesh Thiruganasambandamoorthy1, Kenneth Kwong2, George A Wells2, Marco L A Sivilotti2, Muhammad Mukarram2, Brian H Rowe2, Eddy Lang2, Jeffrey J Perry2, Robert Sheldon2, Ian G Stiell2, Monica Taljaard2.   

Abstract

BACKGROUND: Syncope can be caused by serious conditions not evident during initial evaluation, which can lead to serious adverse events, including death, after disposition from the emergency department. We sought to develop a clinical decision tool to identify adult patients with syncope who are at risk of a serious adverse event within 30 days after disposition from the emergency department.
METHODS: We prospectively enrolled adults (age ≥ 16 yr) with syncope who presented within 24 hours after the event to 1 of 6 large emergency departments from Sept. 29, 2010, to Feb. 27, 2014. We collected standardized variables at index presentation from clinical evaluation and investigations. Adjudicated serious adverse events included death, myocardial infarction, arrhythmia, structural heart disease, pulmonary embolism, serious hemorrhage and procedural interventions within 30 days.
RESULTS: We enrolled 4030 patients with syncope; the mean age was 53.6 years, 55.5% were women, and 9.5% were admitted to hospital. Serious adverse events occurred in 147 (3.6%) of the patients within 30 days after disposition from the emergency department. Of 43 candidate predictors examined, we included 9 in the final model: predisposition to vasovagal syncope, heart disease, any systolic pressure reading in the emergency department < 90 or > 180 mm Hg, troponin level above 99th percentile for the normal population, abnormal QRS axis (< -30° or > 100°), QRS duration longer than 130 ms, QTc interval longer than 480 ms, emergency department diagnosis of cardiac syncope and emergency department diagnosis of vasovagal syncope (C statistic 0.88, 95% confidence interval [CI] 0.85-0.90; optimism 0.015; goodness-of-fit p = 0.11). The risk of a serious adverse event within 30 days ranged from 0.4% for a score of -3 to 83.6% for a score of 11. The sensitivity was 99.2% (95% CI 95.9%-100%) for a threshold score of -2 or higher and 97.7% (95% CI 93.5%-99.5%) for a threshold score of -1 or higher.
INTERPRETATION: The Canadian Syncope Risk Score showed good discrimination and calibration for 30-day risk of serious adverse events after disposition from the emergency department. Once validated, the tool will be able to accurately stratify the risk of serious adverse events among patients presenting with syncope, including those at low risk who can be discharged home quickly.
© 2016 Canadian Medical Association or its licensors.

Entities:  

Mesh:

Year:  2016        PMID: 27378464      PMCID: PMC5008955          DOI: 10.1503/cmaj.151469

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  28 in total

Review 1.  Methodologic standards for the development of clinical decision rules in emergency medicine.

Authors:  I G Stiell; G A Wells
Journal:  Ann Emerg Med       Date:  1999-04       Impact factor: 5.721

2.  Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes.

Authors:  James V Quinn; Ian G Stiell; Daniel A McDermott; Karen L Sellers; Michael A Kohn; George A Wells
Journal:  Ann Emerg Med       Date:  2004-02       Impact factor: 5.721

3.  Prospective evaluation and outcome of patients admitted for syncope over a 1 year period.

Authors:  J-J Blanc; C L'Her; A Touiza; B Garo; E L'Her; J Mansourati
Journal:  Eur Heart J       Date:  2002-05       Impact factor: 29.983

Review 4.  Accuracy and quality of clinical decision rules for syncope in the emergency department: a systematic review and meta-analysis.

Authors:  Luis A Serrano; Erik P Hess; M Fernanda Bellolio; Mohammed H Murad; Victor M Montori; Patricia J Erwin; Wyatt W Decker
Journal:  Ann Emerg Med       Date:  2010-10       Impact factor: 5.721

5.  Standardized reporting guidelines for emergency department syncope risk-stratification research.

Authors:  Benjamin C Sun; Venkatesh Thiruganasambandamoorthy; Jeffrey Dela Cruz
Journal:  Acad Emerg Med       Date:  2012-06       Impact factor: 3.451

6.  The Risk stratification Of Syncope in the Emergency department (ROSE) pilot study: a comparison of existing syncope guidelines.

Authors:  Matthew J Reed; David E Newby; Andrew J Coull; Keith G Jacques; Robin J Prescott; Alasdair J Gray
Journal:  Emerg Med J       Date:  2007-04       Impact factor: 2.740

7.  External validation of the San Francisco Syncope Rule in the Canadian setting.

Authors:  Venkatesh Thiruganasambandamoorthy; Erik P Hess; Abdullah Alreesi; Jeffrey J Perry; George A Wells; Ian G Stiell
Journal:  Ann Emerg Med       Date:  2009-11-27       Impact factor: 5.721

8.  Priorities for emergency department syncope research.

Authors:  Benjamin C Sun; Giorgio Costantino; Franca Barbic; Ilaria Bossi; Giovanni Casazza; Franca Dipaola; Daniel McDermott; James Quinn; Matthew Reed; Robert S Sheldon; Monica Solbiati; Venkatesh Thiruganasambandamoorthy; Andrew D Krahn; Daniel Beach; Nicolai Bodemer; Michele Brignole; Ivo Casagranda; Piergiorgio Duca; Greta Falavigna; Roberto Ippoliti; Nicola Montano; Brian Olshansky; Satish R Raj; Martin H Ruwald; Win-Kuang Shen; Ian Stiell; Andrea Ungar; J Gert van Dijk; Nynke van Dijk; Wouter Wieling; Raffaello Furlan
Journal:  Ann Emerg Med       Date:  2014-06-02       Impact factor: 5.721

9.  Comparison of existing syncope rules and newly proposed anatolian syncope rule to predict short-term serious outcomes after syncope in the Turkish population.

Authors:  Kamil Kayayurt; Haldun Akoglu; Onder Limon; Asım Oktay Ergene; Ozcan Yavasi; Serdar Bayata; Nergiz Vanden Berk; Erden Erol Unluer
Journal:  Int J Emerg Med       Date:  2012-04-20

10.  Risk stratification of adult emergency department syncope patients to predict short-term serious outcomes after discharge (RiSEDS) study.

Authors:  Venkatesh Thiruganasambandamoorthy; Ian G Stiell; Marco L A Sivilotti; Heather Murray; Brian H Rowe; Eddy Lang; Andrew McRae; Robert Sheldon; George A Wells
Journal:  BMC Emerg Med       Date:  2014-03-14
View more
  25 in total

1.  The diagnostic challenge: are we missing pulmonary embolism diagnosis in patients with syncope?

Authors:  Elena Campello; Valeria Rossetto; Luca Spiezia; Stefania Vigolo; Sara Maggiolo; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2018-07-18       Impact factor: 3.397

2.  Orthostatic vital signs do not predict 30 day serious outcomes in older emergency department patients with syncope: A multicenter observational study.

Authors:  Jennifer L White; Judd E Hollander; Anna Marie Chang; Daniel K Nishijima; Amber L Lin; Erica Su; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Bret A Nicks; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun
Journal:  Am J Emerg Med       Date:  2019-03-25       Impact factor: 2.469

Review 3.  Shared Decision-Making as the Future of Emergency Cardiology.

Authors:  Marc A Probst; Peter A Noseworthy; Juan P Brito; Erik P Hess
Journal:  Can J Cardiol       Date:  2017-09-22       Impact factor: 5.223

4.  Outcomes in syncope research: it is time to standardize.

Authors:  Martin Huth Ruwald; Brian Olshansky
Journal:  Intern Emerg Med       Date:  2018-03-26       Impact factor: 3.397

5.  Development of a Patient Decision Aid for Syncope in the Emergency Department: the SynDA Tool.

Authors:  Marc A Probst; Erik P Hess; Maggie Breslin; Dominick L Frosch; Benjamin C Sun; Marie-Noelle Langan; Lynne D Richardson
Journal:  Acad Emerg Med       Date:  2018-02-20       Impact factor: 3.451

6.  Clinical Benefit of Hospitalization for Older Adults With Unexplained Syncope: A Propensity-Matched Analysis.

Authors:  Marc A Probst; Erica Su; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Judd E Hollander; Bret A Nicks; Daniel K Nishijima; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun
Journal:  Ann Emerg Med       Date:  2019-05-09       Impact factor: 5.721

7.  Prevalence of Pulmonary Embolism in Patients With Syncope.

Authors:  Giorgio Costantino; Martin H Ruwald; James Quinn; Carlos A Camargo; Frederik Dalgaard; Gunnar Gislason; Tadahiro Goto; Kohei Hasegawa; Padma Kaul; Nicola Montano; Anna-Karin Numé; Antonio Russo; Robert Sheldon; Monica Solbiati; Benjamin Sun; Giovanni Casazza
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

8.  Benefit of hospital admission for detecting serious adverse events among emergency department patients with syncope: a propensity-score-matched analysis of a multicentre prospective cohort.

Authors:  Rohin J Krishnan; Muhammad Mukarram; Bahareh Ghaedi; Marco L A Sivilotti; Natalie Le Sage; Justin W Yan; Paul Huang; Mona Hegdekar; Eric Mercier; Marie-Joe Nemnom; Lisa A Calder; Andrew D McRae; Brian H Rowe; George A Wells; Venkatesh Thiruganasambandamoorthy
Journal:  CMAJ       Date:  2020-10-13       Impact factor: 8.262

9.  Multicenter Emergency Department Validation of the Canadian Syncope Risk Score.

Authors:  Venkatesh Thiruganasambandamoorthy; Marco L A Sivilotti; Natalie Le Sage; Justin W Yan; Paul Huang; Mona Hegdekar; Eric Mercier; Muhammad Mukarram; Marie-Joe Nemnom; Andrew D McRae; Brian H Rowe; Ian G Stiell; George A Wells; Andrew D Krahn; Monica Taljaard
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

10.  Shared Decision Making for Syncope in the Emergency Department: A Randomized Controlled Feasibility Trial.

Authors:  Marc A Probst; Michelle P Lin; Jeremy J Sze; Erik P Hess; Maggie Breslin; Dominick L Frosch; Benjamin C Sun; Marie-Noelle Langan; Venkatesh Thiruganasambandamoorthy; Lynne D Richardson
Journal:  Acad Emerg Med       Date:  2020-04-02       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.